Neuroprotective effects of Bak Foong Pill in 1-methyl-4-phenyl-1,2,3,6-tetrahyrdropyridine (MPTP)-induced Parkinson's disease model mice

被引:8
作者
Liu, B
Xie, JX
Rowlands, DK
Gou, YL
Leung, CC
Chung, YW
Chan, HC [1 ]
机构
[1] Chinese Univ Hong Kong, Fac Med, Dept Physiol, Epithelial Cell Biol Res Ctr, Hong Kong, Hong Kong, Peoples R China
[2] Qingdao Univ, Coll Med, Dept Physiol, Qingdao 266021, Peoples R China
关键词
Bak Foong Pill; estrogen; Parkinson's disease; tyrosine hydroxylase; dopamine transporter;
D O I
10.1248/bpb.27.1245
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Neuroprotective effects of estrogen and estrogen-like chemicals on neurodegenerative diseases, especially Parkinson's disease, have been well established. In the present study, we compared the effects of Bak Foong Pill (BFP), a well-known gynaecological tonic in China, and 17,beta-estradiol, on dopamine transporter (DAT) and tyrosine hydroxylase (TH) gene expression patterns in ovariectomized, 1-methyl-4-phenyl-1,2,3,6-tetrahyrdropyridine (MPTP)-induced Parkinson's disease (PD) model mice, using multiplex reverse transcription-polymerase chain reaction(RT-PCR). MPTP, a specific dopaminergic neurotoxin, significantly decreased DAT and TH mRNA levels in the striatum, midbrain and cerebellum, but not the cortex, of C57BL/6 mice. However, MPTP-challenge with BFP pretreatment demonstrated reduced neurotoxicity, with DAT and TH mRNA levels either not affected by MPTP or affected to a significantly lesser extent in the midbrain and striatum as compared to the MPTP treated controls. 17beta-estradiol treatment prevented MPTP-induced reduction of DAT expression in striatum and midbrain, but failed to alter TH expression. These results suggest that BFP is able to protect dopaminergic neurons against MPTP-induced neuronal damage in a mechanism that is different from the protective effect of estrogen.
引用
收藏
页码:1245 / 1250
页数:6
相关论文
共 45 条
[1]   Effect of manganese exposure on MPTP neurotoxicities [J].
Baek, SY ;
Lee, MJ ;
Jung, HS ;
Kim, HJ ;
Lee, CR ;
Yoo, C ;
Lee, JH ;
Lee, H ;
Yoon, CS ;
Kim, YH ;
Park, J ;
Kim, JW ;
Joen, BS ;
Kim, Y .
NEUROTOXICOLOGY, 2003, 24 (4-5) :657-665
[2]   Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice [J].
Battaglia, G ;
Busceti, CL ;
Pontarelli, F ;
Biagioni, F ;
Fornai, F ;
Paparelli, A ;
Bruno, V ;
Ruggieri, S ;
Nicoletti, F .
NEUROPHARMACOLOGY, 2003, 45 (02) :155-166
[3]   Neuroprotection against oxidative stress by estrogens: Structure-activity relationship [J].
Behl, C ;
Skutella, T ;
Lezoualch, F ;
Post, A ;
Widmann, M ;
Newton, CJ ;
Holsboer, F .
MOLECULAR PHARMACOLOGY, 1997, 51 (04) :535-541
[4]   EMERGING DIVERSITIES IN THE MECHANISM OF ACTION OF STEROID-HORMONES [J].
BRANN, DW ;
HENDRY, LB ;
MAHESH, VB .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 52 (02) :113-133
[5]   Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (MPP+) towards dopaminergic mesencephalic neurones in primary culture [J].
Callier, S ;
Le Saux, M ;
Lhiaubet, AM ;
Di Paolo, T ;
Rostène, W ;
Pelaprat, D .
JOURNAL OF NEUROCHEMISTRY, 2002, 80 (02) :307-316
[6]   Ginsenoside Rg1 attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stress [J].
Chen, XC ;
Zhu, YG ;
Zhu, LA ;
Huang, C ;
Chen, Y ;
Chen, LM ;
Fang, F ;
Zhou, YC ;
Zhao, CH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 473 (01) :1-7
[7]   Dehydroepiandrosterone (DHEA) such as 17β-estradiol prevents MPTP-induced dopamine depletion in mice [J].
D'Astous, M ;
Morissette, M ;
Tanguay, B ;
Callier, S ;
Di Paolo, T .
SYNAPSE, 2003, 47 (01) :10-14
[8]   Differences in dopaminergic neuroprotective effects of estrogen during estrous cycle [J].
Datla, KP ;
Murray, HE ;
Pillai, AV ;
Gillies, GE ;
Dexter, DT .
NEUROREPORT, 2003, 14 (01) :47-50
[9]   Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice [J].
Dluzen, DE ;
McDermott, JL ;
Liu, BJ .
NEUROTOXICOLOGY AND TERATOLOGY, 1996, 18 (05) :603-606
[10]   Prospects for new restorative and neuroprotective treatments in Parkinson's disease [J].
Dunnett, SB ;
Björklund, A .
NATURE, 1999, 399 (6738) :A32-A39